2 ASX blue chip shares tipped as buys

Are you looking to bolster your portfolio with the addition of a few quality blue chip shares?

Then you’re in luck, here are two top blue chips that have recently been tipped as buys.

Cochlear is a global leader in the design, manufacture, and selling of implantable hearing devices. It has been a consistently strong performer over the last decade thanks to the increasing demand for its products due to the ageing populations tailwind and its world-class product range.

The latter has been underpinned by its high level of investment in research and development (R&D). In FY 2020, Cochlear spent $185 million or ~14% of revenue on R&D. This is expected to increase to between $190 million and $195 million in FY 2021 as management…